In vitro and in vivo activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of Mycobacterium tuberculosis (M. tb )Source: Eur Respir J 2005; 26: Suppl. 49, 700s Year: 2005
The effect on imipenem on the regulation of ampC and oprD genes in Pseudomonas biofilm Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010
Effect of salbutamol on the growth, virulence and biofilm formation of pseudomonas aeruginosa Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011
The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus , Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009
In vitro evaluation of Isoxyl, a mycolic acid inhibitor in combination with rifampicin and Isoniazide against mycobacteria other than M. tuberculosis Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010
In-vitro effect of bioactive fractions of Cinnamomum verum(Cv) on cytokine levels in Mycobacterium tuberculosis (MTB) infected Macrophages. Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Survival of mycobacterium tuberculosis (MBT) on model surfaces Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Pre-clinical study of specific activity and specificity of recombinant diagnostic preparation DIASKINTEST based on proteins ESAT-6 and CFP10 in guinea-pigs infected with M. tuberculosis Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010
Survival due to reduced apoptosis: Importance of the ESX-1 secretion system of Mycobacterium tuberculosis Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010
Influence of glutoxim and its derivatives on the growth of mycobacterium tuberculosis (Mtb) Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
In vitroM.tuberculosis H37Rv inhibition with levofloxacin encapsulated in PLGA particles Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Inhibition of A. fumigatus growth by human respiratory cells Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Unexpectedly high incidence of pneumothorax in patients with pulmonary Mycobacterium avium complex infection Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
In vitro and vivo study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of mycobacterium tuberculosis (M.tb)Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Interferon-γ gene polymorphisms on interferon-γ production affects susceptibility and treatment response to tuberculosis in Japanese populationSource: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Autophagy modulation by Mycobacterium tuberculosis in vitro infection of macrophages Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010
Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009
Efficiency of bactericidal activity of liposomal mycobacteriophages against intracellular Mycobacteria tuberculosis in the model of macrophages RAW 264 Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
In vitro activity of triclosan ( TCN ) and thiolactomycin ( TLM ) against multi-drug-resistant ( MDR ) strains of mycobacterium tuberculosis ( M. tb ) Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001